Compare ORIQ & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIQ | MNOV |
|---|---|---|
| Founded | 2024 | 2000 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.6M | 72.7M |
| IPO Year | 2025 | 2005 |
| Metric | ORIQ | MNOV |
|---|---|---|
| Price | $10.12 | $1.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 16.0K | ★ 80.9K |
| Earning Date | 01-01-0001 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $257,917.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.98 | $1.13 |
| 52 Week High | $10.20 | $2.20 |
| Indicator | ORIQ | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 35.86 |
| Support Level | N/A | $1.25 |
| Resistance Level | N/A | $1.34 |
| Average True Range (ATR) | 0.00 | 0.05 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 0.00 | 18.50 |
Origin Investment Corp I is a blank check company.
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.